Prophylaxis against venous thromboembolism in orthopedic surgery

Chinese Journal of Traumatology - English Edition

Volumn 9, Issue 4, 2006, Pages 249-256

  Liu, Lin Tao ^a   Ma, Bao Tong ^a  

^a TIANJIN HOSPITAL   (China)

Author keywords

Orthopedics; Prophylaxis; Venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; BLOOD CLOTTING FACTOR 10A INHIBITOR; D DIMER; ENOXAPARIN; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; MELAGATRAN; RECOMBINANT THROMBOMODULIN; WARFARIN; XIMELAGATRAN;

ACCURACY; AGING; ASIA; BLADDER DYSFUNCTION; BLEEDING TENDENCY; CAUSE OF DEATH; COMPRESSION THERAPY; CONTRACTURE; CRITICALLY ILL PATIENT; DECISION SUPPORT SYSTEM; DECUBITUS; DEEP VEIN THROMBOSIS; DISABILITY; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG HALF LIFE; ENTEROPATHY; EVIDENCE BASED MEDICINE; FRAGILITY FRACTURE; HEAD INJURY; HIGH RISK PATIENT; HUMAN; IMMOBILIZATION; INCIDENCE; LABORATORY TEST; LUNG EMBOLISM; MOBILIZATION; MULTIPLE TRAUMA; ORTHOPEDIC SURGERY; OSTEOPOROSIS; PATIENT SELECTION; PELVIS FRACTURE; PHLEBOGRAPHY; PHYSICAL ACTIVITY; POSTOPERATIVE PERIOD; PREDICTION; PROPHYLAXIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SPINE FRACTURE; SURVIVAL RATE; TREATMENT INDICATION; VENA CAVA FILTER; VENOUS THROMBOEMBOLISM;

EID: 33747200153     PISSN: 10081275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. Lewandowski K, Szturmowicz M, Fijalkowska A, et al. Pulmonary embolism in course of deep vein thrombosis of lower extremities in patient with bilateral femoral bone fracture after car accident injuries. Pneumonol Alergol Pol 2002;70:203-209.
2. Muntz JE. The risk of venous thromboembolism in non-large-joint surgeries. Orthopedics 2003;26 (2 Suppl): s237-242.
3. Hak DJ. Prevention of venous thromboembolism in trauma and long bone fractures. Curr Opin Pulm Med 2001;7: 338-343.
4. Ennis RS. Postoperative deep vein thrombosis prophylaxis: a retrospective analysis in 1000 consecutive hip fracture patients treated in a community hospital setting. J South Orthop Assoc 2003;12:10-17.
5. Maxwell RA, Chavarria-Aguilar M, Cockerham WT, et al. Routine prophylactic vena cava filtration is not indicated after acute spinal cord injury. J Trauma 2002;52:902-906.
6. Tran AH, Lee G. Fondaparinux for prevention of venous thromboembolism in major orthopedic surgery. Ann Pharmacother 2003;37:1632-1643.
7. Cifu DX, Kaelin DL, Wall BE. Deep venous thrombosis: incidence on admission to a brain injury rehabilitation program. Arch Phys Med Rehabil 1996;77:1182-1185.
8. Wang F, Wera G, Knoblich GO, Chou LB. Pulmonary embolism following operative treatment of ankle fractures: a report of three cases and review of the literature. Foot Ankle Int 2002;23:406-410.
9. Anderson FA Jr, Spencer FA. Risk factors for venous thromboembolism. Circulation 2003;107:I9-16.
10. Edmonds MJ, Crichton TJ, Runciman WB, et al. Evidence-based risk factors for postoperative deep vein thrombosis. ANZ J Surg 2004;74:1082-1097.
11. Britt LD, Zolfaghari D, Kennedy E, et al. Incidence and prophylaxis of deep vein thrombosis in a high risk trauma population. Am J Surg 1996;172:13-14.
12. Anglen JO, Bagby C, George R. A randomized comparison of sequential-gradient calf compression with intermittent plantar compression for prevention of venous thrombosis in orthopedic trauma patients: preliminary results. Am J Orthop 1998;27:53-58.
13. Flordal PA, Berggvist D, Burmark US, et al. Risk factors for major thromboembolism and bleeding tendency after elective general surgical operations. The Fragmin Multicentre Study Group. Eur J Surg 1996;162:783-789.
14. Velmahos GC, Kern J, Chan LS, et al. Prevention of venous thromboembolism after injury: an evidence-based report-part II: analysis of risk factors and evaluation of the role of vena caval filters. J Trauma 2000;49:140-144.
15. Lassen MR, Borris LC, Nakov RL. Use of the low-molecular-weight heparin reviparin to prevent deep-vein thrombosis after leg injury requiring immobilization. N Engl J Med 2002;347:726-730
16. Wenzl ME, Hasse W, Seide K, et al. Prevention of thromboembolism with low-molecular-weight heparin in orthopedic surgery: a 5-year experience. Clin Appl Thromb Hemost 2004;10:1-4.
17. Hurbanek JG, Jaffer AK, Morra N, et al. Postmenopausal hormone replacement and venous thromboembolism following hip and knee arthroplasty. Thromb Haemost 2004;92:337-343.
18. Lin PP, Graham D, Hann LE, et al. Deep venous thrombosis after orthopedic surgery in adult cancer patients. J Surg Oncol 1998;68:41-47.
19. Kew J, Lee YL, Davey IC, et al. Deep vein thrombosis in elderly Hong Kong Chinese with hip fractures detected with compression ultrasound and Doppler imaging: incidence and effect of low molecular weight heparin. Arch Orthop Trauma Surg 1999;119:156-158.
20. Piotrowski JJ, Alexander JJ, Brandt CP, et al. Is deep vein thrombosis surveillance warranted in high-risk trauma patients? Am J Surg 1996;172:210-213.
21. Kvasnicka J, Briza J, Trca S. Prevention of thromboembolism in surgery of fractures of the upper end of the femur. Sb Lek 2002;103:203-212.
22. Velmahos GC, Nigro J, Tatevossian R, et al. Inability of an aggressive policy of thromboprophylaxis to prevent deep venous thrombosis (DVT) in critically injured patients: are current methods of DVT prophylaxis insufficient? J Am Coll Surg 1998;181:529-533.
23. Car D, Bajs ID, Lajtman Z, et al. Prevention of thromboembolism and survival after trauma. Acta Med Croatica 2003;57:99-103.
24. O'reilly RF, Burgess IA, Zicat B. The prevalence of venous thromboembolism after hip and knee replacement surgery. Med J Aust 2005;182:154-159.
25. Lieberman DV, Lieberman D. Proximal deep vein thrombosis after hip fracture surgery in elderly patients despite thromboprophylaxis. Am J Phys Med Rehabil 2002;81:745-750.
26. Liew NC, Moissinac K, Gul Y. Postoperative venous thromboembolism in Asia: a critical appraisal of its incidence. Asian J Surg 2003;26:154-158.
27. Peetz D, Hafner G, Hansen M, et al. Dose-adjusted thrombosis prophylaxis in trauma surgery according to levels of D-Dimer. Thromb Res 2000;98:473-483.
28. Dahl OE, Gudmundsen TE, Bjornara BT, et al. Risk of clinical pulmonary embolism after joint surgery in patients receiving low-molecular-weight heparin prophylaxis in hospital: a 10-year prospective register of 3, 954 patients. Acta Orthop Scand 2003;74:299-304.
29. Gallus AS. Applying risk assessment models in orthopaedic surgery: overview of our clinical experience. Blood Coagul Fibrinolysis 1999;10:S53-61.
30. Kearon C. Duration of venous thromboembolism prophylaxis after surgery. Chest 2003;124:386S-392S.
31. Kher A, Samama MM. Primary and secondary prophylaxis of venous thromboembolism with low-molecular-weight heparins: prolonged thromboprophylaxis, an alternative to vitamin K antagonists. J Thromb Haemost 2005;3:473-481.
32. Kolb G, Bodamer I, Galster H, et al. Reduction of venous thromboembolism following prolonged prophylaxis with the low molecular weight heparin Certoparin after endoprothetic joint replacement or osteosynthesis of the lower limb in elderly patients. Thromb Haemost 2003;90:1100-1105.
33. Messieh M, Huang Z, Johnson LJ, et al. Warfarin responses in total joint and hip fracture patients. J Arthroplasty 1999;14:724-729.
34. Brotman DJ, Jaffer AK, Hurbanek JG, et al. Warfarin prophylaxis and venous thromboembolism in the first 5 days following hip and knee arthroplasty. Thromb Haemost 2004;92: 1012-1017.
35. Bridges GG, Lee MD, Jenkins JK, et al. Expedited discharge in trauma patients requiring anticoagulation for deep venous thrombosis prophylaxis: the LEAP Program. J Trauma 2003;54:232-235.
36. Thaler HW, Roller RE, Greiner N, et al. Thromboprophylaxis with 60 mg enoxaparin is safe in hip trauma surgery. J Trauma 2001;51:518-521.
37. Deitelzweig SB, Vanscoy GJ, Niccolai CS, et al. Venous thromboembolism prevention with LMWHs in medical and orthopedic surgery patients. Ann Pharmacother 2003;37: 402-411.
38. Eriksson BI, Lassen MR; PENTasaccharide in HIp-FRActure Surgery Plus Investigators. Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study. Arch Intern Med 2003;163: 1337-1342.
39. Tran AH, Lee G. Fondaparinux for prevention of venous thromboembolism in major orthopedic surgery. Ann Pharmacother 2003;37:1632-1643.
40. Turpie AG, Bauer KA, Eriksson BI, et al. Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. Arch Intern Med 2002;162: 1806-1808.
41. Eriksson BI, Bauer KA, Lassen MR, et al. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. N Engl J Med 2001;345:1298-1304.
42. Turpie AG, Bauer KA, Eriksson BI, et al. Superiority of fondaparinux over enoxaparin in preventing venous thromboembolism in major orthopedic surgery using different efficacy end points. Chest 2004;126:501-508.
43. Turpie AG. The design of venous thromboembolism prophylaxis trials: fondaparinux is definitely more effective than enoxaparin in orthopaedic surgery. Int J Clin Pract 2004;58: 483-493.
44. Gordois A, Posnett J, Borris L, et al. The cost-effectiveness of fondaparinux compared with enoxaparin as prophylaxis against thromboembolism following major orthopedic surgery. De J Thromb Haemost 2003;1:2167-2174.
45. Hawkins D. Clinical trials with factor Xa inhibition in the prevention of postoperative venous thromboembolism. Am J Health Syst Pharm. 2003;60:S6-10.
46. Hardy JF. Best evidence in anesthetic practice: prevention: fondaparinux is better than enoxaparin for prevention of major venous thromboembolisin after orthopedic surgery. Can J Anaesth 2003;50:764-766.
47. Turpie AG, Eriksson BI, Lassen MR, et al. A meta-analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgery. J South Orthop Assoc 2002;11:182-188.
48. Sullivan SD, Davidson BL, Kahn SR, et al. A cost-effectiveness analysis of fondaparinux sodium compared with enoxaparin sodium as prophylaxis against venous thromboembolism: use in patients undergoing major orthopaedic surgery. Pharmacoeconomics 2004;22:605-620.
49. McCullough PA, Dorrell KA, Sandberg KR, et al. Ximelagatran: a novel oral direct thrombin inhibitor for long-term anticoagulation. Rev Cardiovasc Med 2004;5:99-103.
50. Andersen JC. Advances in anticoagulation therapy: the role of selective inhibitors of factor Xa and thrombin in thromboprophylaxis after major orthopedic surgery. Semin Thromb Hemost 2004;30:609-618.
51. Hawkins D. The role of oral direct thrombin inhibitors in the prophylaxis of venous thromboembolism. Pharmacotherapy 2004;24:179S-183S.
52. Hamaad A, Tayebjee MH, Lip GY. The METHRO trials. Expert Opin Investig Drugs 2003;12:865-870.
53. Eriksson BI. Clinical experience of melagatran/ximelagatran in major orthopaedic surgery. Thromb Res 2003; 109 Suppl 1:S23-29.
54. Kwok L, Boucher M. Ximelagatran for prevention and treatment of venous thromboembolism. Issues Emerg Health Technol 2004;57:1-4.
55. Glynn O. The express study: preliminary results. Int J Clin Pract 2003;57:57-69.
56. Eriksson BI, Agnelli G, Cohen AT, et al. Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after total hip or knee replacement. Thromb Haemost 2003;89:288-296.
57. Kearon C, Comp P, Douketis J, et al. Dose-response study of recombinant human soluble thrombomodulin (ART-123) in the prevention of venous thromboembolism after total hip replacement. J Thromb Haemost 2005;3:962-968.
58. Langan EM 3rd, Miller RS, Casey WJ 3rd, et al. Prophylactic inferior vena cava filters in trauma patients at high risk: follow-up examination and risk/benefit assessment. J Vasc Surg 1999;30:484-488.
59. Wolf F, Thurnher S, Lammer J. Simon nitinol vena cava filters: effectiveness and complications. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 2001;173:924-930.
60. Rousseau H, Perreault P, Otal P, et al. The 6-F nitinol TrapEase inferior vena cava filter: results of a prospective multicenter trial. J Vasc Interv Radiol 2001;12:299-304.
61. Spence LD, Gironta MG, Malde HM, et al. Acute upper extremity deep venous thrombosis: safety and effectiveness of superior vena caval filters. Radiology 1999;210:53-58.
62. Matchett WJ, Jones MP, McFarland DR, et al. Suprarenal vena caval filter placement: follow-up of four filter types in 22 patients. J Vasc Interv Radiol 1998;9:588-593.
63. Spain DA, Bergamini TM, Hoffmann JF, et al. Comparison of sequential compression devices and foot pumps for prophylaxis of deep venous thrombosis in high-risk trauma patients. Am Surg 1998;64:522-526.
64. Stannard JP, Riley RS, McClenney MD, et al. Mechanical prophylaxis against deep-vein thrombosis after pelvic and acetabular fractures. J Bone Joint Surg Am 2001;83-A: 1047-1051.
65. Kennedy JG, Soffe KE, Rogers BW, et al. Deep vein thrombosis prophylaxis in hip fractures: a comparison of the arteriovenous impulse system and aspirin. J Trauma 2000;48: 268-272.
66. LaBan MM, Martin T, Pechur J, et al. Physical and occupational therapy in the treatment of patients with multiple sclerosis. Phys Med Rehabil Clin N Am 1998;9:603-614.